Xinmiao Qu

ORCID: 0009-0003-9790-6836
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Platelet Disorders and Treatments
  • Blood groups and transfusion
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Iron Metabolism and Disorders
  • Chronic Lymphocytic Leukemia Research
  • Viral Infections and Outbreaks Research
  • Immunodeficiency and Autoimmune Disorders
  • Eosinophilic Disorders and Syndromes
  • RNA modifications and cancer
  • COVID-19 epidemiological studies
  • Acute Myeloid Leukemia Research
  • SARS-CoV-2 and COVID-19 Research
  • Blood properties and coagulation

Institute of Hematology & Blood Diseases Hospital
2023-2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2023-2024

City University of Hong Kong
2021

Assessing the effects of non-pharmaceutical interventions (NPIs) and vaccines on controlling coronavirus disease 2019 (COVID-19) is key for each government to optimize anti-contagion policy according their situation.We proposed Braking Force Model Virus Transmission evaluate validity efficiency NPIs vaccines. This model classified administration at different effectiveness levels forecasted duration required control pandemic, providing an indication future trends pandemic wave.This was...

10.46234/ccdcw2021.195 article EN China CDC Weekly 2021-01-01

Summary The coronavirus disease 2019 (COVID‐19) pandemic has a significant impact on the immune system. This is first and largest study pre‐existing thrombocytopenia (ITP) patients infected with COVID‐19 in China. We prospectively collected ITP enrolled National Longitudinal Cohort of Hematological Diseases (NICHE, NCT04645199) followed up for at least 1 month after infection. One thousand one hundred forty‐eight were included. Two twelve (18.5%) showed decrease platelet (PLT) count...

10.1111/bjh.19198 article EN British Journal of Haematology 2023-11-15
Coming Soon ...